Ian Mortimer, PRESIDENT & CEO at Xenon Pharmaceuticals Inc. (XENE), sold 14,616 shares at $55.23 ($807K) on 2026-03-13, disclosed to the SEC on 2026-03-13.
Open-market sale of $807k XENE by PRESIDENT & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.23 | 7,308 | $404K | 50.0% |
| 2 | $55.23 | 7,308 | $404K | 50.0% |
| Total | $55.23 avg | 14,616 | $807K | 100% |
| Filing → |
| XENE | SELL | 2026-01-02 | $1.8M | — | Filing → |
| XENE | SELL | 2025-12-09 | $2.3M | — | Filing → |
| XENE | SELL | 2025-12-03 | $4K | — | Filing → |